Jump to content

Clebopride

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 80.42.29.84 (talk) at 07:45, 6 September 2015 (Synthesis). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Clebopride
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro-
    2-methoxybenzamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.054.424 Edit this at Wikidata
Chemical and physical data
FormulaC20H24ClN3O2
Molar mass373.876 g/mol g·mol−1
3D model (JSmol)
  • Clc1cc(c(OC)cc1N)C(=O)NC3CCN(Cc2ccccc2)CC3
  • InChI=1S/C20H24ClN3O2/c1-26-19-12-18(22)17(21)11-16(19)20(25)23-15-7-9-24(10-8-15)13-14-5-3-2-4-6-14/h2-6,11-12,15H,7-10,13,22H2,1H3,(H,23,25) checkY
  • Key:BVPWJMCABCPUQY-UHFFFAOYSA-N checkY
  (verify)

Clebopride is a dopamine antagonist drug with antiemetic and prokinetic properties used to treat functional gastrointestinal disorders. Chemically, it is a substituted benzamide, closely related to metoclopramide.

A small Spanish study found that more adverse reactions are reported with clebopride than with metoclopramide, particularly extrapyramidal symptoms.[1]

Synthesis

Dopamine receptor antagonist related to metoclopramide, q.v.

Clebopride synthesis:[2][3]

The benzoic acid moiety common to many of the benzamides is prepared in a straightforward manner from the methyl ether of 4-aminosalicylic acid 1. Acetylation on nitrogen followed by chlorination gives intermediate 3; benzoic acid 4 is then obtained by removal of the acetyl group. Condensation of this acid with an aminopiperidine could be achieved by means of the mixed anhydride (prepared by reaction with ethyl chloroformate), which affords clebopride (5).

See also

References

  1. ^ Cuena Boy R, Maciá Martínez MA (1998). "[Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System]". Atencion Primaria (in Spanish). 21 (5): 289–95. PMID 9608114. Free full text
  2. ^ R. G. Spickett et al., DE 2513136 ; A. V. Noverola et al., U.S. patent 4,138,492 (1975, 1979 both to Anphar).
  3. ^ Template:Cite PMID